Danazol 100mg and 200mg capsules have been discontinued in the UK and remaining supplies of both strengths are now exhausted.
Danazol has several licensed indications and off-label uses. The management of patients prescribed danazol for licensed indications will differ to those prescribed danazol for an off-label use.
A limited quantity of unlicensed supplies of danazol 100mg and 200mg capsules have been sourced.
This alert contains advice on the management of affected patients.
Please note that no response is required via the CAS website to this alert.
We have updated the alert pdf to amend a link to the Breast Pain clinical knowledge summary in the 'Advice on switching patients to alternative therapies' section.